"GEN: Awake, alert, and oriented\nHEENT: PERRLA. MMM. no JVD. neck supple. No cervical LAD\nCards: RRR, S1/S2 normal. II/VI systolic ejection murmur heard\nbest at the L upper sternal border.\nPulm: CTABL with no crackles or wheezes.\nAbd: BS+, soft, NT, no rebound/guarding, no HSM, no [**Doctor Last Name 515**]\nsign\nExtremities: wwp, no edema. radials, DPs, PTs 2+.\nSkin: no rashes or bruising. no skin tenting.\nNeuro: CNs II-XII intact. Upper extremities: Power [**5-6**]\nbilaterally. Le: left power: 4.5/5  right: power [**3-6**].  Bilateral\nsymmetric, reduced sensation distal LE to ankles.\n\n\nPertinent Results:\nAdmission Labs: [**2117-9-11**] 09:22AM\nWBC-11.9* RBC-4.58 HGB-13.0 HCT-36.5 MCV-80* PLT COUNT-466*\nLIPASE-22  ALT(SGPT)-10 AST(SGOT)-16 ALK PHOS-105 TOT BILI-0.5\nGLUCOSE-260* UREA N-48* CREAT-2.7* SODIUM-137 POTASSIUM-4.9\nCL-101 CO2-11*\nLACTATE-1.9\n\nDischarge Labs: [**2117-9-16**] 07:10AM\nWBC-6.8 RBC-3.67* Hgb-10.4* Hct-30.2* MCV-82 Plt Ct-298\nGlucose-118* UreaN-20 Creat-2.3* Na-137 K-3.7 Cl-104 HCO3-23\nAnGap-14\nCalcium-8.7 Phos-3.5 Mg-2.0\n\nRadiology:\nCXR: No evidence of pneumonia or other pathological\nabnormalities. No\npleural effusions. No pulmonary edema. Normal size of the\ncardiac\nsilhouette.\n\nMicrobiology: Urine culture negative, blood cultures no growth\nto date, stool for C.difficile negative\n\n\nBrief Hospital Course:\n35 yo F with HTN & poorly controlled type I DM, c/b neuropathy,\ngastroparesis, nephropathy ?????? CKD, retinopathy presents with DKA\nand hypertension SBP to 200s.\n.\n# Diabetic ketoacidosis: Patient controls diabetes at home with\nHumalog SS and long acting Levemir.  Sugars at home recently\nhave been in 250s. In the ED, glucose was 466. UA was +ve for\nketones ?????? corrected to 200s, but rose again to 300s. She was\ntreated with an insulin drip which was transitioned to subq when\nshe tolerated POs. Her electrolytes were repleted and she\nreceived aggressive volume resuscitation. [**Last Name (un) **] saw her and\ngave sliding scale recommendations which were implemented. No\nsource for DKA found, beleived to be [**2-3**] gastroparesis. Nausea\nmanaged with ativan, compazine, and promethazine. She was\ndischarged on her home Insulin and sliding scale with\ninstructions to follow-up with [**Last Name (un) **].\n\n# HTN: Hypertensive with SBP in 190s initially, attributed to\nDKA, as she has experienced in the past. As she improved her\nblood pressures normalized and she was re-started on her home\nLopressor and Midodrine regimen.\n\n# Coffee grounds emesis: Emesis started off as clear, then with\nprolonged wretching, she started having coffee-grounds vomiting.\nThis had also occurred on prior admissions for DKA with\nassociated vomiting. Her hematocrit remained stable and her\nhematemesis self-resolved, and so work-up was deferred to the\noutpatient setting.\n\n# Acute on chronic kidney disease, Stage III: Patient's Cr on\nadmission was 2.7, trending down to 2.1-2.3 following fluids,\nconsistent with her known CKD secondary to diabetic nephropathy.\n\n\nMedications on Admission:\n1. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).\n\n2. Levemir 100 unit/mL Solution Sig: Twenty Two (22) units\nSubcutaneous every AM.\n3. Levemir 100 unit/mL Solution Sig: Twelve (12) units\nSubcutaneous at bedtime.\n4. Humalog 100 unit/mL Solution Sig: sliding scale as directed\nSubcutaneous four times a day: Please use sliding scale as\ndirected by MD [**First Name8 (NamePattern2) 767**] [**Last Name (Titles) **].\n5. metoprolol tartrate 50 mg Tablet Sig: 1.5 Tablets PO DAILY\n(Daily): take in the evening.\n6. promethazine 25 mg Tablet Sig: 0.5 Tablet PO Q8H (every 8\nhours) as needed for nausea.\n7. gabapentin 300 mg Capsule Sig: One (1) Capsule PO Q12H (every\n\n12 hours).\nDisp:*60 Capsule(s)* Refills:*2*\n8. duloxetine 30 mg Capsule, Delayed Release(E.C.) Sig: Two (2)\nCapsule, Delayed Release(E.C.) PO DAILY (Daily): Please take\nonly 1 capsule daily (30 mg) for first 2 weeks of treatment.\nDisp:*60 Capsule, Delayed Release(E.C.)(s)* Refills:*2*\n9. oxycodone 5 mg Capsule Sig: One (1) Capsule PO every eight\n(8) hours as needed for pain.\n10. midodrine 5 mg Tablet Sig: 1.5 Tablets PO every four (4)\nhours: Can hold while sleeping.\nDisp:*270 Tablet(s)* Refills:*2*\n\n\nDischarge Medications:\n1. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).\n\n2. gabapentin 300 mg Capsule Sig: One (1) Capsule PO Q12H (every\n12 hours).\n3. duloxetine 30 mg Capsule, Delayed Release(E.C.) Sig: One (1)\nCapsule, Delayed Release(E.C.) PO DAILY (Daily).\n4. metoprolol tartrate 25 mg Tablet Sig: Three (3) Tablet PO\nOnce Daily at 6 PM.\n5. midodrine 2.5 mg Tablet Sig: Three (3) Tablet PO DAILY\n(Daily).\n6. Levemir 100 unit/mL Solution Sig: As directed by [**Last Name (un) **] units\nSubcutaneous As directed.\n\n\nDischarge Disposition:\nHome\n\nDischarge Diagnosis:\nDiabetic keotacidosis\nHematemesis (blood in your vomit)\nHypertension\nChronic renal insufficiency\n\nDischarge Condition:\nMental Status: Clear and coherent.\nLevel of Consciousness: Alert and interactive.\nActivity Status: Ambulatory - Independent.\n\nDischarge Instructions:\nYou were admitted to the hospital with DKA, hypertension, and\nblood in your vomit. You were initially treated in the ICU with\nan insulin drip, and your blood sugars improved. Your blood\npressure medications were adjusted to better control your blood\npressure while you were in DKA, but you were re-started on your\nhome regimen at discharge. The blood in your vomit was likely\nsecondary to mechanical trauma from repeated wretching, but you\nshould follow-up with your primary care doctor to discuss\nwhether you should undergo further evaluation such as an upper\nendoscopy. Given your complaints of chronic cough and heartburn,\nyou should also discuss beginning a trial of a proton pump\ninhibitor such as Nexium or Prilosec to see if this helps your\nsymptoms.\n\nYour insulin regimen was adjusted by the [**Last Name (un) **] team while you\nwere here. You should continue to follow-up with them with any\nquestions or concerns regarding your insulin management."